Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner

Neuroscience

Volumn 90, Issue 4, 1999, Pages 1217-1226

  Yang, D S ^a   Small, D H ^b   Seydel, U ^a   Smith, J D ^c   Hallmayer, J ^a   Gandy, S E ^d   Martins, R N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

amyloid; Alzheimer's disease; Apolipoprotein E; Chinese hamster ovary cells; Heparan sulphate proteoglycans; LDL receptor related protein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHO CELL; CONFOCAL LASER MICROSCOPY; GENETIC RISK; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHO CELLS; CRICETINAE; HEPARIN; PEPTIDE FRAGMENTS; RECEPTORS, LDL;

EID: 0032903412     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00561-2     Document Type: Article

References (36)

1. Beffert U., Aumont N., Dea D., Lussier-Cacan S., Davignon J., Poirier J. β-Amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J. Neurochem. 70:1998;1458-1466.
2. Burdick D., Kosmoski J., Knauer M. F., Glabe C. G. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1-42, in differentiated PC12 cells. Brain Res. 746:1997;275-284.
3. Chan W., Fornwald J., Brawner M., Wetzel R. Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide amyloid beta. Biochemistry. 35:1996;7123-7130.
4. Chartier-Harlin M. C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V.et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. molec. Genet. 3:1994;569-574.
5. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
6. Dai X. Y., Nanko S., Hattori M., Fukuda R., Nagata K., Isse K., Ueki A., Kazamatsuri H. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci. Lett. 175:1994;74-76.
7. Dichek H. L., Brecht W., Fan J., Ji Z. S., McCormick S. P., Akeefe H., Conzo L., Sanan D. A., Weisgraber K. H., Young S. G., Taylor J. M., Mahley R. W. Over expression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. biol. Chem. 273:1998;1896-1903.
8. Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., van Duijn C. M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. med. Ass. 278:1997;1349-1356.
9. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120:1984;885-890.
10. Guillaume D., Dea D., Davignon J. and Poirier J. (1995) Low-density lipoprotein pathways in the central nervous system and apolipoprotein E isoform-specific differences. In Research Advances in Alzheimer's Disease and Related Disorders (eds Iqbal K., Mortimer J. A., Winblad B. and WisniewskiH. M.), pp. 385-395. John Wiley, Chichester.
11. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci. Lett. 174:1994;222-224.
12. Ida N., Masters C. L., Beyreuther K. Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells. Fedn Eur. biochem. Socs Lett. 394:1996;174-178.
13. Jarrett J. T., Berger E. P., Lansbury P. T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 11:1993;4693-4697.
14. Ji Z. S., Mahley R. W. Lactoferrin binding to heparin sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14:1994;2025-2031.
15. Ji Z. S., Brecht W. J., Miranda R. D., Hussain M. M., Innerarity T. L., Mahley R. W. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. biol. Chem. 268:1993;10,160-10,167.
16. Kaess H. O. (1989) Statistical Concepts for Behavioral Sciences. Allyn & Bacon, Boston.
17. Kounnas M. Z., Moir R. D., Rebeck G. W., Bush A. I., Argraves W. S., Tanzi R. E., Hyman B. T., Strickland D. K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell. 82:1995;331-340.
18. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., Frail D. E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. biol. Chem. 269:1994;23,403-23,406.
19. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., Falduto M. T. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J. biol. Chem. 270:1995;9039-9042.
20. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J. C., Anthony D. C., Koo E. H., Goate A. M., Selkoe D. J., Arango J. C. The E280A presenilin 1 Alzheimer mutation produces increased amyloid beta 42 deposition and severe cerebellar pathology. Nat. Med. 2:1996;1146-1150.
21. Martins R. N., Clarnette R., Fisher C., Broe G. A., Brooks W. S., Montgomery P., Gandy S. E. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport. 6:1995;1513-1516.
22. Mayeux R., Stern Y., Ottman R., Tatemichi T. K., Tang M. X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann. Neurol. 34:1993;752-754.
23. Mentlein R., Ludwig R., Martensen I. Proteolytic degradation of Alzheimer's disease amyloid β-peptide by a metalloproteinase from microglia cells. J. Neurochem. 70:1998;721-726.
24. Miyata M., Smith J. D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14:1996;55-61.
25. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
26. Paresce D. M., Ghosh R. N., Maxifield F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
27. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
28. Saunders A. M., Schmader K., Breitner J. C., Benson M. D., Brown W. T., Goldfarb L., Goldgaber D., Manwaring M. G., Szymanski M. H., McCown N.et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 18:1993;710-711.
29. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T. D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
30. Shaffer L. M., Dority M. D., Gupta-Bansal R., Frederickson R. C. A., Younkin S. G., Brunden K. R. Amyloid β peptide (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
31. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;1977-1981.
32. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:1993;166-168.
33. Van Regenmortel M. H. V., Briand J. P., Muller S. and Plaue S. (1988) Synthetic Polypeptides as Antigens, Vol. 19, pp. 159-174. Elsevier, Amsterdam.
34. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
35. Yang D. S., Smith J. D., Zhou Z., Gandy S. E., Martins R. N. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68:1997;721-725.
36. Zhou Z., Smith J. D., Greengard P., Gandy S. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E. Molec. Med. 2:1996;175-180.